Do health workers’ preferences influence their practices? Assessment of providers’ attitude and personal use of new treatment recommendations for management of uncomplicated malaria, Tanzania

BMC Public Health

Rashid A Khatib²  Angelina M Lutambi¹  Irene M Masanja¹ 

[1] Universität Basel, Petersplatz 1, Basel, CH, 4003, Switzerland;Ifakara Health Institute, Po Box 78373, Dar es Salaam, Tanzania

关键词: Malaria;    New treatment guidelines;    Practices;    Attitude;    Health workers;   

Others  :  1162873
DOI  :  10.1186/1471-2458-12-956

 received in 2012-04-11, accepted in 2012-10-16,  发布年份 2012

【 摘 要 】

Background

Due to growing antimalarial drug resistance, Tanzania changed malaria treatment policies twice within a decade. First in 2001 chloroquine (CQ) was replaced by sulfadoxine-pyrimethamine (SP) for management of uncomplicated malaria and by late 2006, SP was replaced by artemether-lumefantrine (AL). We assessed health workers’ attitudes and personal practices following the first treatment policy change, at six months post-change and two years later.

Methods

Two cross-sectional surveys were conducted in 2002 and 2004 among healthcare workers in three districts in South-East Tanzania using semi-structured questionnaires. Attitudes were assessed by enquiring which antimalarial was considered most suitable for the management of uncomplicated malaria for the three patient categories: i) children below 5; ii) older children and adults; and iii) pregnant women. Practice was ascertained by asking which antimalarial was used in the last malaria episode by the health worker him/herself and/or dependants. Univariate and multivariate logistic regression was used to identify factors associated with reported attitudes and practices towards the new treatment recommendations.

Results

A total of 400 health workers were interviewed; 254 and 146 in the first and second surveys, respectively. SP was less preferred antimalarial in hospitals and private health facilities (p<0.01) in the first round, and the preference worsened in the second round. In the first round, clinicians did not prefer SP for children below age of 5 and pregnant women (p<0.01), but two years later, they did not prefer it for all patient scenarios. SP was the most commonly used antimalarial for management of the last malaria episode for health workers and their dependants in both rounds, in the public sector (p<0.01). Health workers in the dispensaries had the highest odds of using SP for their own treatment [adjusted OR- first round: 6.7 (95%CI: 1.9-23.4); crude OR- second round: 4.5 (1.5-13.3)].

Conclusion

Following changes in malaria treatment recommendations, most health workers did not prefer the new antimalarial drug, and their preferences worsened over time. However, many of them still used the newly recommended drug for management of their own or family members’ malaria episode. This indicates that, other factors than providers’ attitude may have more influence in their personal treatment practices.

【 授权许可】

   
2012 Masanja et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Ministry of Health: National malaria medium term strategic plan 2002–2007. Dar es Salaam: National Malaria Control Programme; 2003. [Malaria control series 8]
• [2]Ministry of Health: National guidelines for malaria diagnosis and treatment. United Republic of Tanzania: Ministry of Health; 2000. [Malaria control series 1]
• [3]Ministry of Health: Management of uncomplicated and severe malaria; Prescribers manual. Part 1- Learner’s guide, 3rd edition. United Republic of Tanzania: National Malaria Control Programme; 2003. [Malaria Control Series 7]
• [4]World Health Organization: World malaria situation in 1993, part I. Wkly Epidemiol Rec 1996, 71:17-22.
• [5]Snow RW, Craig MH, Deichmann U, Marsh K: Estimating mortality, morbidity and disability due to Malaria among Africa’s non-pregnant population. Bull World Health Organ 1999, 77:624-640.
• [6]Ministry of Health: Diagnosis and treatment of malaria orientation guide for district trainers. United Republic of Tanzania: National Malaria Control Programme. Ministry of Health; 2005. [Malaria control series 10]
• [7]Mubyazi GM, Gonzalez-Block MA: Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Malaria J 2005, 4:51. BioMed Central Full Text
• [8]Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck H, Mshinda H: Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. AmJTrop Med Hyg 2004, 71(6):696-702.
• [9]Gorissen E, Ashruf G, Lamboo M, Bennebroek J, Gikunda S, Mbaruku G, Kager P: A In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Trop Med Int Health 2000, 5:459-463.
• [10]Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC: High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg 1996, 90:179-181.
• [11]Schellenberg D, Kahigwa E, Drackeley C, Malende A, Wigayi J, Msokame C, Aponte JJ, Tanner M, Mshinda H, Menendez C, Alonso P: The safety and efficacy of sulfadoxine pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. AmJTrop Med Hyg 2002, 67:17-23.
• [12]Nsimba Stephen ED: How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy. J Ethnobiol Ethnomed 2006, 10:2-5.
• [13]Zurovac D, Rowe AK, Ochola SA, Noor AM, Midia B, English M, Snow RW: Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya. Int J Epidemiol 2004, 33(5):1080-1091.
• [14]Dodoo ANO, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D: Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to Artemisinin-combination therapy. Malaria J 2009, 8:2. BioMed Central Full Text
• [15]Tarimo DS, Minja JN, Bygberg IC: Perceptions of Chloroquine efficacy and alternative treatments for uncomplicated malaria in children in a holoendemic area of Tanzania: implications for the change in policy. Trop Med Int Health 2001, 6:992-997.
• [16]Wakgari D, Ahmed A, Fikre E: Knowledge, attitude and practice about malaria, the mosquito and antimalarial drugs in a rural community. Ethiop J Heal Dev 1999, 17(2):99-104.
• [17]Okolo SN, Ogbonna C: Knowledge, attitude and practice of health workers in keffi local government hospitals regarding baby-friendly hospital initiative (BFHI) practices. Eur J Clin Nutr 2002, 56:326-337.
• [18]Olowookere SA: Awareness and attitude of health workers at a Nigerian HIV treatment clinic towards HIV/AIDS and HAART adherence. J Int Assoc Physicians AIDS Care 2009, 3:208-212. 1018
• [19]Ignacio LL, DeArango MV: Knowledge and attitude of primary health care personnel concerning mental health. Int J Epidemiol 1989, 18:669-673.
• [20]Wasunna B, Zurovac D, Goodman CA, Snow RW: Why don’t health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malaria J 2008, 7:29. BioMed Central Full Text
• [21]Zurovac D, Tibendarana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW: Malaria case-management under Artemether-lumefantrine treatment policy in Uganda. Malaria J 2008, 7:181. BioMed Central Full Text
• [22]Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW: Paediatric malaria case management with artemether-lumefantrine in Zambia: a repeated cross sectional study. Malaria J 2007, 6:31. BioMed Central Full Text
• [23]Zurovac D, Njogu J, Akhwale W, Hamer DH, Larson BA, Snow RW: Effects of revised diagnostic recommendations on malaria treatment across age groups in Kenya. Trop Med Int Health 2008, 13:784-787.